INTRODUCTION
Thyroid hormones play essential roles in the processes of metabolism, growth and development in most vertebrate tissues (Lazar, 2003) . Although there are abundant literature data concerning the molecular mechanisms of thyroid hormone action in various biochemical and physiological processes (Goglia et al., 1999) , little is known about the possible genotoxic and mutagenic effects of thyroid hormones and/or their metabolites.
However, it is well established that thyroid hormones increase aerobic metabolism in mitochondria which causes intense production of reactive oxygen and nitrogen species, leading to the condition of oxidative stress (Venditti et al., 2003; Fernandez et al., 2005) . In addition, binding of thyroid hormone to specific nuclear receptors in target cells induces enzymes related to redox processes and the total rate of oxygen consumption is enhanced (Oppenheimer et al., 1996) . Reactive oxygen species (ROS) induced by thyroid hormones may cause lipid and protein oxidation in rat hepatocytes (Tapia et al., 1999) . Moreover, experimentally induced hyperthyroidism is accompanied by an increased rate of O 2 consumption and enhanced microsomal oxidative capacity and generation of ROS in the rat liver (Fernandez et al., 2003) . Interestingly, creation of oxidative stress is even more potentated by thyroid hormone-induced decrease of superoxide dismutase (SOD) and catalase activities, as well as by the reduced glutathione content in the liver cells (Fernandez et al., 1988) . This depression of key antioxidative mechanisms favors oxidative stress in the liver (Tapia et al., 1999) .
Overwhelming evidence indicates that oxidative stress can lead to DNA damage and mutations (Sakai et al., 2006; Lankoff et al., 2006) . Indeed, there are some indices that thyroid hormones can induce oxidative stress accompanied by DNA damage in human lymphocytes (Djeli} and Anderson, 2003) and sperm (Dobrzynska et al., 2004) evaluated by the Comet assay in vitro. On the other hand, thyroxine exhibited only weak clastogenic effects expressed as an increased sister chromatid exchange, without a significant increase in micronucleus frequencies in cultured human peripheral blood lymphocytes (Djeli} et al., 2006) . It should be noted, however, that these equivocal data were obtained using whole blood cultures, whereas DNA damage in the Comet assay was observed on purified human lymphocytes. Namely, it is possible that enzymes catalase and gluthathione peroxidase which are normally present in erytrocytes in whole blood cultures can reduce the effects of reactive oxygen species (Andreoli et al., 1999) which may be produced under the influence of thyroid hormones.
Since the evaluation of cytogenetic effects of thyroxine in cultured human lymphocytes was equivocal, in the present study we aimed to investigate the possible cytogenetic changes in bone marrow cells of Swiss albino mice, after acute or subacute exposure to L-thyroxine. Therefore, this investigation should further elucidate the possbile clastogenic and/or aneugenic effects of thyroid hormones. It is particularly interesting that the effects of thyroid hormones were monitored on cells exposed in vivo.
MATERIALS AND METHODS
Test substance and controls. The test substance used for the evaluation of the possible genotoxic effects was L-thyroxine (CAS No 51-48-9, Sigma Chemical Co., St. Louis, MO, USA) dissolved in 0.1 M NaOH. The solvent was used as a negative control, whereas the well known mutagen N-methyl-N'-nitro-Nnitrosoguanidine (MNNG, CAS No 70-25-7, Sigma Chemical Co., St. Louis, MO, USA) dissolved in dimethylsulfoxide (DMSO) was chosen as the positive control.
Animals. In this investigation we used Swiss albino mice from the Institute of immunobiology and virusology "Torlak" (Belgrade). All animals were acclimatized for 7 days prior to the start of the experiments. Animals were kept under standard conditions: room temperature (21±1) o C, humidity 55-60%, food and water ad libitum, standard daily illumination. For each experimental and control group 4 males weighting 20-25 g were used.
In vivo cytogenetic test. Animals were divided into several groups: negative control (solvent-treated), positive control (treated with the well known mutagen MNNG) and thyroid hormone-treated animals. Three doses of T 4 (0.1 mg/kg, 0.5 mg/kg and 2.5 mg/kg were used. Animals were treated with intraperitoneal T 4 injection for 1, 3 and 7 and 10 days. After the last treatment, after 24 h, the animals were treated with colchicine (Sigma chemical Co., St. Louis, MO, USA, final concentration 4mg/kg) in order to cause metaphase arrest. Two hours after the treatment the femures in ether anesthesia were removed. Chromosome preparations were made according to the method of Evans and O'Riordan (1975) as previously described in detail (Djeli} et al., 1996) . Bone marrow was isolated in 0.9% w/v NaCl. After centrifugation cell pellets were treated with hypotonic solution (0.075M KCl) for 20 min at 37 o C. Afterwards, three repetitive cycles of fixation in methanol-acetic acid (3:1, v/v) were performed. After the last fixation we resuspended the cell pellet in 0.5 mL of supernatant to which one drop of 60% CH 3 COOH was added. Finally, a few drops of cell pellet were air dried and stained with 5% Giemsa (Merck, Darmstadt, Germany). In order to determine the mitotic index at least 1000 cells per experimental animal were scored, and for chromosome lesions and aberrations 100 metaphase spreads per animal were analysed.
Statistical analysis. The statistical analysis of cytogenetic endpoints was performed by c 2 test using the Statgraph 4.2 software. Mitotic indices were analysed by z-test. A P-value of £ 0.05 was considered as indicative of statistical significance for all tests used.
RESULTS
Results of the mitotic indices in thyroxine-treated animals and controls are presented in Table 1 . Evidently, mitotic index is not significantly changed at all doses of thyroxine following the 24 h treatment. Treatment for 3 days caused a significant decrease (P<0.01) in mitotic index only at the highest experimental concentration (2.5 mg/kg). Likewise, after 7 and 10 days of treatment only the highest concentration of thyroxine significantly (P<0.001) decreased MI. As expected, the positive control (10 -6 M MNNG) caused a significant decrease of MI at all time periods. However, the suppresion of mitotic activity caused by MNNG was more profound at longer periods of treatment with thyroxine. MI -mitotic index, S.D. -standard deviation; **P<0.01; ***P<0.001 (z-test) a) one animal died on the 3rd day of treatment b) one animal died on the 2nd day of treatment c) one animal died on the 6th day, and one animal died on 9th day of treatment d) two mice died on 8th and 9th day of treatment, respectively
As for chromosome lesions and aberrations, generally there was no significant effect of thyroxine, at all concentrations and time periods. The most common aberration was aneuploidy, probably because it can also occur as an artefact during chromosome preparation. Therefore, these results are in accordance with our previous investigations of genotoxic effects of thyroxine showing no effect on micronucleus induction in human peripheral blood lymphocytes in vitro. Only the positive control (MNNG) gave a significant (P<0.001) rise of overall aberrations, when comapred to the negative control. Also, it should be noted that the increased frequency of chromosome aberrations was correlated with MNNG treatment duration ( Table 2 ). 25 .50*** CA -chromosome aberrations; ctg -chromatid gap; csg -chromosome gap; ctb -chromatid break; csb -chromosomal break; acf -acentric fragment; cf -centric fusion; ane -aneuploidy; polpolyploidy ***P<0.001 (c 2 -test) a) one animal died on the 3rd day of treatment b) one animal died on the 2nd day of treatment c) one animal died on the 6th day, and one animal died on 9th day of treatment d) two mice died on 8th and 9th day of treatment, respectively Finally, it has to be mentioned that animal deaths were observed. Namely, one animal in group treated with 0.5 mg/kg of T 4 for 3 days died on the third day of treatment. Also, one animal in the group treated for 7 days died on day 2 of treatment with 0.1 mg/kg T 4 , and two animals died (on days 6 and 9 respectively) in the group treated for 10 days with 2.5 mg/kg. As for the positive control, we observed that two mice died on the 8th and 9th day of treatment with MNNG.
DISCUSSION
There is abundant literature data about the genotoxic and mutagenic effects of environmental pollutants (Pitarque et al. 2002; Stanimirovi} et al., 2005) . Most of the environmental genotoxins result from intense development of chemical and other industries. Therefore, they increase in number each year. However, there is an increasing evidence that some substances which are normally present in the human or animal bodies may, under certain circumstances, exhibit genotoxic effects, therefore acting as endogenous mutagenic agents (Lutz, 1990; Totsuka et al., 2005) . Probably the best studied endogenous mutagenic agents are oestrogenic hormones Schallreuter et al., 2006) .
The principal molecular mechanism of the genotoxic effects of oestrogens comprises their metabolic conversion to catecholoestrogens and subsequent redox cycling creating the condition of oxydative stress (Liehr, 2001; Li et al., 2004) . Interestingly, there are some experimental indices that phenolic groups of some non-steroidal hormones (adrenaline, thyroid hormone) and neurotransmitters (dopamine, noradrenaline) may undergo redox cycling accompanied by generation of ROS favoring oxidative stress (Moldeus et al., 1983; Djeli} and Anderson, 2003; Dobrzynska et al., 2004) . Therefore, the induction of oxidative stress may be the key mechanism of genotoxic effects of both steroidal and non-steroidal hormones with phenolic groups.
There is an experimental confirmation that thyroid hormones can induce DNA damage in human lymphocytes (Djeli} and Anderson, 2003) and sperm (Dobrzynska et al, 2004 ) measured by the Comet assay. Namely, the DNA damage measured by tail moment was significantly reduced in cells concomitantly treated with thyroid hormone and the antioxidant enzyme catalase. On the other hand, thyroxine induced SCEs in whole blood cultures, whereas there was no increase in micronuclei (MN) (Djeli} et al., 2006) . It is generally acknowledged that SCE test is an indicator test of genotoxic exposure, whereas MN test represents a mutagenicity test for detection of chromosome aberrations. Therefore, the results of MN test should be considered of higher significance than the results of SCE test. In previous investigations we considered that thyroxine has not exhibited mutagenic effects in cultured human lymphocytes. Anyhow, since the molecular mechanism(s) of SCE formation and their biological significance remain unclear, we undertook this investigation to evaluate possible chromosome alterations under in vivo conditions. The negative results obtained in this in vivo investigation are in complete accordance with the absence of mutagenic effects in the MN assay on human lymphocytes in vitro. This is quite logical, because MN assay detects acentric fragments and/or whole chromosomes left behind during the nuclear division and are visible as small additional nuclei. Moreover, our experimental results on Swiss albino mice are particularly valuable showing that thyroxine did not induce chromosome mutations under the in vivo conditions. Also, we monitored effects of thyroxine during subacute treatment of up to 10 days and there was no significant change in chromosome aberrations compared to the negative control.
Finally, our results of both in vivo and in vitro cytogenetic analysis of the genotoxic effects of thyroxine disagree with findings that thyroid hormones produce profound DNA damaging effects in human lymphocytes (Djeli} and Anderson, 2003) and sperm (Dobryznska et al., 2004) . This discrepancy may have been caused because the Comet assay was performed on purified lymphocytes. Namely, erythrocytes in whole blood cultures contain catalase and glutathione peroxidase, which eliminate hydrogen peroxide (Andreoli et al., 1999; Karaca et al., 2006) . These antioxidant enzymes can reduce the effects of ROS created primarily by the action of thyroid hormones on mitochondria. We also assume that under the in vivo conditions antioxidant defence mechanisms (Benzie, 2000) could have reduced the genotoxic effects of thyroxine. In addition, it must be emphasised that the Comet assay has a much higher sensitivity than standard cytogenetic analysis (Tice et al., 2000) .
